Literature DB >> 15372580

Complexing mechanism of the lanthanide cations Eu3+, Gd3+, and Tb3+ with 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (dota)-characterization of three successive complexing phases: study of the thermodynamic and structural properties of the complexes by potentiometry, luminescence spectroscopy, and EXAFS.

Juliette Moreau1, Emmanuel Guillon, Jean-Claude Pierrard, Jean Rimbault, Marc Port, Michel Aplincourt.   

Abstract

Complexation of the lanthanides Eu3+, Gd3+, and Tb3+ with 1,4,7,10-tetrakis(carboxymethyl)-1,4,7,10-tetraazacyclododecane (dota) has been studied in solution by using potentiometry, luminescence spectrometry, and EXAFS. Three series of successive complexes were characterized by at least two of these methods: the immediate [LnHn(dota)](n-1)+** and intermediate [LnHn(dota)](n-1)+* complexes with 0 </= n </= 2, and the final [Ln(dota)]- complexes. The formation constants of the intermediate and final complexes were determined by using potentiometry. From the results, a complexation mechanism involving three steps has been proposed. In the [LnHn(dota)](n-1)+** complexes that are instantaneously formed, the lanthanide is bound to four oxygen atoms of the carboxylate groups and to five water molecules. These species evolve rapidly: the lanthanide moves into the macrocycle cavity, two new bonds are formed with two nitrogen atoms diametrically opposed in the tetraaza cycle and only three water molecules remain bound to the lanthanide in the [LnHn(dota)](n-1)+* (0 </= n </= 2) complexes, which appear after a two-day wait. These compounds are stable for about four days. After 4-8 weeks, a concerted rearrangement occurs which leads to the formation of thermodynamically stable [Ln(dota)]- complexes in which the lanthanide is bound to four nitrogen atoms, four carboxylate oxygen atoms, and one water molecule.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15372580     DOI: 10.1002/chem.200400006

Source DB:  PubMed          Journal:  Chemistry        ISSN: 0947-6539            Impact factor:   5.236


  24 in total

Review 1.  The biological fate of gadolinium-based MRI contrast agents: a call to action for bioinorganic chemists.

Authors:  Mariane Le Fur; Peter Caravan
Journal:  Metallomics       Date:  2019-02-20       Impact factor: 4.526

2.  Preparation and long-term biodistribution studies of a PAMAM dendrimer G5-Gd-BnDOTA conjugate for lymphatic imaging.

Authors:  Ana Christina Opina; Karen J Wong; Gary L Griffiths; Baris I Turkbey; Marcelino Bernardo; Takahito Nakajima; Hisataka Kobayashi; Peter L Choyke; Olga Vasalatiy
Journal:  Nanomedicine (Lond)       Date:  2014-11-13       Impact factor: 5.307

Review 3.  Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Authors:  Thaddeus J Wadas; Edward H Wong; Gary R Weisman; Carolyn J Anderson
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 4.  Alternatives to gadolinium-based metal chelates for magnetic resonance imaging.

Authors:  Subha Viswanathan; Zoltan Kovacs; Kayla N Green; S James Ratnakar; A Dean Sherry
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 5.  Bifunctional chelates for metal nuclides.

Authors:  M W Brechbiel
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-11-28       Impact factor: 2.346

Review 6.  Targeted alpha-therapy: past, present, future?

Authors:  Martin W Brechbiel
Journal:  Dalton Trans       Date:  2007-09-11       Impact factor: 4.390

7.  Analysis of the conformational behavior and stability of the SAP and TSAP isomers of lanthanide(III) NB-DOTA-type chelates.

Authors:  Gyula Tircso; Benjamin C Webber; Benjamin E Kucera; Victor G Young; Mark Woods
Journal:  Inorg Chem       Date:  2011-08-05       Impact factor: 5.165

8.  Engineering an antibody with picomolar affinity to DOTA chelates of multiple radionuclides for pretargeted radioimmunotherapy and imaging.

Authors:  Kelly Davis Orcutt; Adrian L Slusarczyk; Maryelise Cieslewicz; Benjamin Ruiz-Yi; Kumar R Bhushan; John V Frangioni; K Dane Wittrup
Journal:  Nucl Med Biol       Date:  2010-10-27       Impact factor: 2.408

9.  Design of (Gd-DO3A)n-polydiamidopropanoyl-peptide nucleic acid-D(Cys-Ser-Lys-Cys) magnetic resonance contrast agents.

Authors:  Nariman V Amirkhanov; Ivan Dimitrov; Armin W Opitz; Kaijun Zhang; John P Lackey; Christopher A Cardi; Song Lai; Norman J Wagner; Mathew L Thakur; Eric Wickstrom
Journal:  Biopolymers       Date:  2008-12       Impact factor: 2.505

10.  (S)-5-(p-nitrobenzyl)-PCTA, a promising bifunctional ligand with advantageous metal ion complexation kinetics.

Authors:  Gyula Tircsó; Eniko Tircsóné Benyó; Eul Hyun Suh; Paul Jurek; Garry E Kiefer; A Dean Sherry; Zoltán Kovács
Journal:  Bioconjug Chem       Date:  2009-03-18       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.